Allarity TherapeuticsALLR
13F holders, Q3 2024 (September 30)4holders
$2.11avg. 13F price*
At the end of Q3 2024, 4 institutions reported holding Allarity Therapeutics Inc. (ALLR) in their 13F filings. The largest holders were UBS Group AG ($39K), Tower Research Capital LLC (TRC) ($7K) and Bank of America Corp. ($23).
- Company
- Allarity Therapeutics Inc.
- CUSIP
- 016744500
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $46K |
| Exits | 0 | $0 |
Ownership 4 holders
| UBS Group AG | 0.00% | New | 18,452 | $39K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 3,403 | $7K |
| Bank of America Corp. | 0.00% | New | 11 | $23 |
| Danske Bank A/S | 0.00% | New | 8 | $17 |
"% of holder's portfolio" is ALLR's weight in each manager's 13F, not the share of Allarity Therapeutics Inc. the manager owns.